114 related articles for article (PubMed ID: 2864195)
1. Activation of washed chicken thrombocytes by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (platelet-activating factor).
Cox CP
Comp Biochem Physiol A Comp Physiol; 1985; 82(1):145-51. PubMed ID: 2864195
[TBL] [Abstract][Full Text] [Related]
2. Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets.
Cox CP
Thromb Res; 1986 Jan; 41(2):211-22. PubMed ID: 2421432
[TBL] [Abstract][Full Text] [Related]
3. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
5. 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: influence on aggregation and [3H]serotonin release of human thrombocytes.
Korth R; Hillmar I; Muramatsu T; Zöllner N
Chem Phys Lipids; 1983 Jul; 33(1):47-53. PubMed ID: 6627525
[TBL] [Abstract][Full Text] [Related]
6. Effect of synthetic phospholipids on platelet aggregation and serotonin release.
Söling U; Eibl H; Nagel GA; Unger C
Lipids; 1987 Nov; 22(11):868-70. PubMed ID: 3444380
[TBL] [Abstract][Full Text] [Related]
7. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
8. 1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen.
Hornby EJ; Perry CR
Thromb Haemost; 1983 Aug; 50(2):586-7. PubMed ID: 6636035
[TBL] [Abstract][Full Text] [Related]
9. A novel platelet-activating protein derived from rat submandibular glands.
Cox CP; Quissell DO
Thromb Res; 1985 Aug; 39(3):343-53. PubMed ID: 4049321
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of platelet activating factor-induced aggregation and secretion in human platelets.
McCulloch RK; Vandongen R
Prostaglandins; 1990 Jan; 39(1):13-21. PubMed ID: 2106712
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.
Valone FH; Johnson B
J Immunol; 1985 Feb; 134(2):1120-4. PubMed ID: 2578151
[TBL] [Abstract][Full Text] [Related]
12. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.
Korth R; Riess H; Brehm G; Hiller E
Thromb Res; 1986 Mar; 41(5):699-706. PubMed ID: 3961742
[TBL] [Abstract][Full Text] [Related]
13. Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam.
Cox CP; Wood KL
Thromb Res; 1987 Aug; 47(3):249-57. PubMed ID: 3629553
[TBL] [Abstract][Full Text] [Related]
14. Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet.
Janero DR; Burghardt B; Burghardt C
Thromb Res; 1988 Jun; 50(6):789-802. PubMed ID: 3413730
[TBL] [Abstract][Full Text] [Related]
15. Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets.
Wade PJ; Lunt DO; Lad N; Tuffin DP; McCullagh KG
Thromb Res; 1986 Jan; 41(2):251-62. PubMed ID: 3961730
[TBL] [Abstract][Full Text] [Related]
16. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
Ostermann G; Till U; Thielmann K
Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
[TBL] [Abstract][Full Text] [Related]
17. Production of platelet-activating factor by washed rabbit platelets.
Oda M; Satouchi K; Yasunaga K; Saito K
J Lipid Res; 1985 Nov; 26(11):1294-9. PubMed ID: 3934305
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
Nunez D; Kumar R; Hanahan DJ
Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
Kornecki E; Ehrlich YH; Lenox RH
Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
[TBL] [Abstract][Full Text] [Related]
20. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor.
Suzuki Y; Miwa M; Harada M; Matsumoto M
Eur J Biochem; 1988 Feb; 172(1):117-20. PubMed ID: 3345757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
